| 摘要 |
Ophthalmic pharmaceutical compositions useful in controlling elevated intraocular pressure associated with glaucoma and other ophthalmic conditions are described. A method of controlling elevated intraocular pressure with those compositions is also described. The compositions contain a sympathomimetic agent having beta-2 agonist activity to enhance the outflow of aqueous humor, and a beta-1 selective beta-blocker to reduce production of aqueous humor, whereby therapeutic control of intraocular pressure is achieved. |
